Author: OurCrowd

In the News: The most active venture investor in Israel is…

For the second year in a row, we are pleased to share that OurCrowd was again named by PitchBook as the most active venture investor in Israel! It was a pleasure to be interviewed for this thoughtful opinion piece from Hong Kong’s leading journal: Start-up nation: Are there lessons to be learned from Israel’s tech success? Check this out from Bloomberg – There are signs of a revival in Israeli IPOs. Startup Nation and beyond What’s new in funding rounds: Israeli car laser sensor company Innoviz raises $132M, fintech startup Rewire raises $12M, and CyberX raises $18M to protect industrial control systems from cyberattack.  Israeli startups are being seen. In its largest acquisition in 20 years, McDonald’s is acquiring Dynamic Yield to create a more customized drive-thru and Alibaba acquires Israeli startup Infinity Augmented Reality. In an effort to fuel Israel’s tech industry growth: 3 NGOs team up in bid to boost tech jobs for Arab, Ethiopian and Haredi Israelis.  Top tech news this week Mobility…The war to remotely control self-driving cars heats up, featuring Phantom Auto. Enterprise Software…The closest thing to teleporting tech support to your home, featuring TechSee. Cybersecurity…ThetaRay CEO...

Read More

Israel’s Flower Power: Startup Nation is leading the Cannabis Tech Revolution

As the rest of the world catches on to the positive impact of medical marijuana, Israel is ready to hit ‘go’ on CannabisTech – and impact lives around the world. Israel recently joined the ranks of a very small global club. It is now only the third country in the world to legally export medical-grade cannabis, joining Canada and the Netherlands. Finalized in January 2019, the new law unlocks a potential billion-dollar industry for Israel annually, not to mention a global market valued to reach $56 billion by 2025, according to a market forecast from Grand View Research. Download OurCrowd’s 2019 Cannabis Industry Report Historically the research of cannabis in the United States, and globally, has been limited due to its categorization as a Schedule 1 narcotic (alongside the likes of heroin and ecstasy). The Ministry of Health in Israel, on the other hand, has been researching cannabis since the 1960’s and monitoring medical cannabis since 2001, making it one of the first countries to do so. As a result, it has played a starring role in the rise...

Read More